Clinical Trial Update: Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of gemcitabine, capecitabine, and erlotinib in patients with advanced pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED